Vehicle Controls: The Solvent Is an Experimental Variable
A tidy dose-response curve turns up in a system that offers no obvious mechanism for one. Before crediting the peptide, consider what else got more concentrated as the dose went up. Whatever the compound was dissolved in came along with it, and so did whatever the powder was a salt of. Neither is inert, both are absent from the untreated wells, and left uncontrolled either becomes the leading candidate for the result.
A concentration series is also a salt series
Start here because this confounder has no counterpart in small-molecule work and slips past almost everyone. Trifluoroacetate arrives bound to the material as a counter-ion, and in a trifluoroacetate salt it can account for a meaningful share of the powder by mass. Add twice as much peptide and you have added twice as much trifluoroacetate. What that does is covered in counter-ions and salt form.
The consequence for experimental design is sharp. Dose-dependence proves nothing about the peptide when the counter-ion has the identical dependence. A solvent-only control cannot rescue this, since the counter-ion scales with the compound and not with the solvent volume.
What settles it is a matched counter-ion condition: the same quantity of salt, no peptide. Hardly anyone runs one. It is nevertheless the right control any time a concentration-dependent effect shows up where none was expected.
Defining the comparison properly
Back up to the general principle. A vehicle control receives every single thing the treated condition received apart from the compound. Identical solvent, identical final concentration, introduced at the same moment, handled the same way throughout.
That definition is strict on purpose. An untreated well does not qualify, since it differs from a treated well in two respects rather than one. Compare against untreated material alone and any observed difference could belong to the compound or to the solvent, with no way to adjudicate between them.
The solvents are not passive
Peptide work relies on a short list of solvents, and each does something at concentrations that are trivially easy to reach.
| Dimethyl sulfoxide | The default for poorly soluble material, and biologically active on its own terms, acting on membranes and on an assortment of cellular processes. Tolerance spans more than an order of magnitude between cell types, so a level that is harmless in one system carries no guarantee in another. |
| Acetic acid | Standard for getting basic peptides into solution, and it moves pH. A dilution that appears trivial can shift a weakly buffered medium by a measurable amount, and pH is not a subtle variable. |
| Ethanol | Biologically active, and it evaporates, meaning its concentration does not stay put across an incubation. |
| Trifluoroacetate | Not a solvent at all. It comes in with the material, in proportion to the amount of peptide added. |
Picking a solvent is itself a consequential decision, which is the subject of choosing a reconstitution solvent. The narrower point for control design is that whatever got chosen must also show up in a control well.
Where the matching breaks
Four failures account for most bad vehicle controls. The most frequent by a wide margin is a series in which final solvent concentration is not held constant. Build each point by pipetting a different volume from a single stock and the solvent tracks the compound perfectly across the whole range; dilute the stock serially first, so that every well takes the same volume, and the problem disappears.
Next, the control has to sit at the solvent level of the highest treatment. Matching it to the lowest concentration leaves the top of the range entirely uncontrolled. Third, handling must be identical: the same tubes, the same tips, the same interval on the bench, the same count of freeze-thaws. A control exists to isolate exactly one variable, and any additional difference ruins it. Fourth, preparations should be the same age. Pairing a control made minutes ago against a compound dilution sitting around since the previous hour lets time in as an uncontrolled factor, which matters given the adsorption described in adsorptive loss to surfaces.
Beyond the solvent
Vehicle controls deal with what the compound was dissolved in. Several peptide-specific confounders demand controls of their own.
With a metal complex, the metal is a live alternative explanation, and a matched salt condition is what separates metal from complex. That is why the controls set out in the copper complex matter for that material. With a blend, the individual components are the controls, and in their absence no effect can be assigned to any single constituent, as explained under multi-peptide blends and demonstrated by the three-component example in the GLOW blend. And whenever purity is less than high, an impurity sitting at a few percent is present at a calculable concentration and stands as a candidate agent in its own right.
What a methods section has to say
Three items belong there: the solvent used, its final concentration in treated wells, and confirmation that a matched vehicle condition was included. Name the solvent but never mention a vehicle control and the question stays open. Report neither and the result simply cannot be interpreted.
The peptide literature is particularly weak on this, since studies tend to be small and methods sections short. Check for it before filing a reported effect under established, alongside the other reading habits described in what the published literature actually shows.
Two halves of the same accounting
A certificate accounts for what is in the vial. A vehicle control accounts for everything else that entered the well. Together they cover the full contents of an experiment apart from the cells, and only once both are settled can a result be pinned on the compound.
Characterizing the material is the easier half, and it is the half that comes with paperwork. The remainder gets assembled in the laboratory, is written down nowhere, and is the source of most results that nobody can explain.
